Quadrant Private Wealth Management »

Leap Therapeutics shares owned by Quadrant Private Wealth Management

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Quadrant Private Wealth Management from 13F filings

Historical chart of Quadrant Private Wealth Management investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Quadrant Private Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Quadrant Private Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.9k 11k 0.79

More positions owned by Quadrant Private Wealth Management

NVIDIA Corporation (NVDA)
Bluerock Pvt Real Estate (BPRE)
Spdr Series Trust State Street Spd (SPYM)
Ishares Tr S&p 500 Val Etf (IVE)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Broadcom (AVGO)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Exxon Mobil Corporation (XOM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Netflix (NFLX)
Snowflake Com Shs (SNOW)

View all positions for Quadrant Private Wealth Management

Top funds holding Leap Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Susquehanna International
Geode Capital Management
Vanguard Fiduciary Trust
Citadel Advisors
UBS Group
LPL Financial
State Street Corporation
Jane Street
Group One Trading
Texas Capital Bank Wealth Management Services
Key Client Fiduciary Advisors
Northern Trust

View all funds holding Leap Therapeutics